Pancreatic cancer: management and survival
Aim: To review the management and survival from all pancreatic cancer over a 5‐year period at a tertiary referral hospital in New Zealand and to examine similar outcome data from the national cancer registry. Methods: A retrospective audit was conducted for the 5‐year period 1994−99 of patients di...
Gespeichert in:
| Veröffentlicht in: | ANZ journal of surgery 2004-11, Vol.74 (11), p.941-944 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 944 |
|---|---|
| container_issue | 11 |
| container_start_page | 941 |
| container_title | ANZ journal of surgery |
| container_volume | 74 |
| creator | Wakeman, Christopher J. Martin, Ian G. Robertson, Robert W. Dobbs, Bruce R. Frizelle, Frank A. |
| description | Aim: To review the management and survival from all pancreatic cancer over a 5‐year period at a tertiary referral hospital in New Zealand and to examine similar outcome data from the national cancer registry.
Methods: A retrospective audit was conducted for the 5‐year period 1994−99 of patients discharged from Christchurch Hospital (Christchurch, New Zealand) and all patients in the New Zealand Cancer Registry with a diagnosis of pancreatic cancer. Kaplan− Meier survival curves were used for analysis.
Results: From Christchurch Hospital a total of 230 patients were identified with a discharge diagnosis of pancreatic cancer. Medium survival for all groups was 3.9 months. There was a median survival of 1.6 months for the non‐interventional group, 3.1 months for the stent group, 6.2 months for the bypass group and 12.6 months for the pancreatico‐duodenectomy group. These data are very similar to the New Zealand National Cancer Registry data, where the overall median survival was 3.1 months and median survival for a pancreatico‐duodenectomy was 13.9 months.
Conclusion: A pancreatico‐duodenectomy is usually a palliative surgical technique and not a curative procedure. Those selected for resection have been shown to have an advantage over operative bypass in terms of length of survival, however, this most likely reflects selection bias. |
| doi_str_mv | 10.1111/j.1445-1433.2004.03210.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67085869</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>824920731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4320-216f899784ca72bc0eb536cae6c6a9d8426ee55cb7b2d3fedeb8299e42846f8e3</originalsourceid><addsrcrecordid>eNqNkEtLAzEUhYMoPqp_QQYXLoTWvCcRXMjgC2pVqrgMmcytTJ2ZatLR-u_N2KLgymxy4H7n3OQglBA8IPEcTweEc9EnnLEBxZgPMKNxtlhD298DSnS6vtIdtIV2QphiTKTUYhNtESEExqneRkd3tnEe7Lx0iYsS_ElS28Y-Qw3NPLFNkYTWv5fvttpFGxNbBdhb3T30eHH-kF31h7eX19nZsO84ozjulhOldaq4synNHYZcMOksSCetLhSnEkAIl6c5LdgECsgV1Ro4VTw6gfXQ4TL31c_eWghzU5fBQVXZBmZtMDLFSiipI3jwB5zOWt_EtxmiFaVCpyJCagk5PwvBw8S8-rK2_tMQbLoyzdR0PZmuJ9OVab7LNIto3V_lt3kNxa9x1V4ETpfAR1nB57-Dzdlo3Kno7y_9ZZjD4sdv_Uv8JEuFeRpdmgxnN_fZeGTG7Att65Aw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198225975</pqid></control><display><type>article</type><title>Pancreatic cancer: management and survival</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Wakeman, Christopher J. ; Martin, Ian G. ; Robertson, Robert W. ; Dobbs, Bruce R. ; Frizelle, Frank A.</creator><creatorcontrib>Wakeman, Christopher J. ; Martin, Ian G. ; Robertson, Robert W. ; Dobbs, Bruce R. ; Frizelle, Frank A.</creatorcontrib><description>Aim: To review the management and survival from all pancreatic cancer over a 5‐year period at a tertiary referral hospital in New Zealand and to examine similar outcome data from the national cancer registry.
Methods: A retrospective audit was conducted for the 5‐year period 1994−99 of patients discharged from Christchurch Hospital (Christchurch, New Zealand) and all patients in the New Zealand Cancer Registry with a diagnosis of pancreatic cancer. Kaplan− Meier survival curves were used for analysis.
Results: From Christchurch Hospital a total of 230 patients were identified with a discharge diagnosis of pancreatic cancer. Medium survival for all groups was 3.9 months. There was a median survival of 1.6 months for the non‐interventional group, 3.1 months for the stent group, 6.2 months for the bypass group and 12.6 months for the pancreatico‐duodenectomy group. These data are very similar to the New Zealand National Cancer Registry data, where the overall median survival was 3.1 months and median survival for a pancreatico‐duodenectomy was 13.9 months.
Conclusion: A pancreatico‐duodenectomy is usually a palliative surgical technique and not a curative procedure. Those selected for resection have been shown to have an advantage over operative bypass in terms of length of survival, however, this most likely reflects selection bias.</description><identifier>ISSN: 1445-1433</identifier><identifier>EISSN: 1445-2197</identifier><identifier>DOI: 10.1111/j.1445-1433.2004.03210.x</identifier><identifier>PMID: 15550079</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Pty</publisher><subject>Adenocarcinoma - mortality ; Adenocarcinoma - surgery ; Adenocarcinoma - therapy ; Aged ; bypass ; Cancer ; Case-Control Studies ; Cholangiopancreatography, Endoscopic Retrograde ; Disease management ; Female ; Humans ; Male ; New Zealand - epidemiology ; palliative ; Palliative Care ; Pancreas ; Pancreatic cancer ; Pancreatic Neoplasms - mortality ; Pancreatic Neoplasms - surgery ; Pancreatic Neoplasms - therapy ; pancreatico-duodenectomy ; Pancreaticoduodenectomy ; Registries - statistics & numerical data ; Retrospective Studies ; stent ; Stents ; Surgery ; survival ; Survival Analysis ; Survival Rate ; Time Factors ; Whipple's operation</subject><ispartof>ANZ journal of surgery, 2004-11, Vol.74 (11), p.941-944</ispartof><rights>2004 Royal Australasian College of Surgeons</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4320-216f899784ca72bc0eb536cae6c6a9d8426ee55cb7b2d3fedeb8299e42846f8e3</citedby><cites>FETCH-LOGICAL-c4320-216f899784ca72bc0eb536cae6c6a9d8426ee55cb7b2d3fedeb8299e42846f8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1445-1433.2004.03210.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1445-1433.2004.03210.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15550079$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wakeman, Christopher J.</creatorcontrib><creatorcontrib>Martin, Ian G.</creatorcontrib><creatorcontrib>Robertson, Robert W.</creatorcontrib><creatorcontrib>Dobbs, Bruce R.</creatorcontrib><creatorcontrib>Frizelle, Frank A.</creatorcontrib><title>Pancreatic cancer: management and survival</title><title>ANZ journal of surgery</title><addtitle>ANZ J Surg</addtitle><description>Aim: To review the management and survival from all pancreatic cancer over a 5‐year period at a tertiary referral hospital in New Zealand and to examine similar outcome data from the national cancer registry.
Methods: A retrospective audit was conducted for the 5‐year period 1994−99 of patients discharged from Christchurch Hospital (Christchurch, New Zealand) and all patients in the New Zealand Cancer Registry with a diagnosis of pancreatic cancer. Kaplan− Meier survival curves were used for analysis.
Results: From Christchurch Hospital a total of 230 patients were identified with a discharge diagnosis of pancreatic cancer. Medium survival for all groups was 3.9 months. There was a median survival of 1.6 months for the non‐interventional group, 3.1 months for the stent group, 6.2 months for the bypass group and 12.6 months for the pancreatico‐duodenectomy group. These data are very similar to the New Zealand National Cancer Registry data, where the overall median survival was 3.1 months and median survival for a pancreatico‐duodenectomy was 13.9 months.
Conclusion: A pancreatico‐duodenectomy is usually a palliative surgical technique and not a curative procedure. Those selected for resection have been shown to have an advantage over operative bypass in terms of length of survival, however, this most likely reflects selection bias.</description><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - surgery</subject><subject>Adenocarcinoma - therapy</subject><subject>Aged</subject><subject>bypass</subject><subject>Cancer</subject><subject>Case-Control Studies</subject><subject>Cholangiopancreatography, Endoscopic Retrograde</subject><subject>Disease management</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>New Zealand - epidemiology</subject><subject>palliative</subject><subject>Palliative Care</subject><subject>Pancreas</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - mortality</subject><subject>Pancreatic Neoplasms - surgery</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>pancreatico-duodenectomy</subject><subject>Pancreaticoduodenectomy</subject><subject>Registries - statistics & numerical data</subject><subject>Retrospective Studies</subject><subject>stent</subject><subject>Stents</subject><subject>Surgery</subject><subject>survival</subject><subject>Survival Analysis</subject><subject>Survival Rate</subject><subject>Time Factors</subject><subject>Whipple's operation</subject><issn>1445-1433</issn><issn>1445-2197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtLAzEUhYMoPqp_QQYXLoTWvCcRXMjgC2pVqrgMmcytTJ2ZatLR-u_N2KLgymxy4H7n3OQglBA8IPEcTweEc9EnnLEBxZgPMKNxtlhD298DSnS6vtIdtIV2QphiTKTUYhNtESEExqneRkd3tnEe7Lx0iYsS_ElS28Y-Qw3NPLFNkYTWv5fvttpFGxNbBdhb3T30eHH-kF31h7eX19nZsO84ozjulhOldaq4synNHYZcMOksSCetLhSnEkAIl6c5LdgECsgV1Ro4VTw6gfXQ4TL31c_eWghzU5fBQVXZBmZtMDLFSiipI3jwB5zOWt_EtxmiFaVCpyJCagk5PwvBw8S8-rK2_tMQbLoyzdR0PZmuJ9OVab7LNIto3V_lt3kNxa9x1V4ETpfAR1nB57-Dzdlo3Kno7y_9ZZjD4sdv_Uv8JEuFeRpdmgxnN_fZeGTG7Att65Aw</recordid><startdate>200411</startdate><enddate>200411</enddate><creator>Wakeman, Christopher J.</creator><creator>Martin, Ian G.</creator><creator>Robertson, Robert W.</creator><creator>Dobbs, Bruce R.</creator><creator>Frizelle, Frank A.</creator><general>Blackwell Science Pty</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200411</creationdate><title>Pancreatic cancer: management and survival</title><author>Wakeman, Christopher J. ; Martin, Ian G. ; Robertson, Robert W. ; Dobbs, Bruce R. ; Frizelle, Frank A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4320-216f899784ca72bc0eb536cae6c6a9d8426ee55cb7b2d3fedeb8299e42846f8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - surgery</topic><topic>Adenocarcinoma - therapy</topic><topic>Aged</topic><topic>bypass</topic><topic>Cancer</topic><topic>Case-Control Studies</topic><topic>Cholangiopancreatography, Endoscopic Retrograde</topic><topic>Disease management</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>New Zealand - epidemiology</topic><topic>palliative</topic><topic>Palliative Care</topic><topic>Pancreas</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - mortality</topic><topic>Pancreatic Neoplasms - surgery</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>pancreatico-duodenectomy</topic><topic>Pancreaticoduodenectomy</topic><topic>Registries - statistics & numerical data</topic><topic>Retrospective Studies</topic><topic>stent</topic><topic>Stents</topic><topic>Surgery</topic><topic>survival</topic><topic>Survival Analysis</topic><topic>Survival Rate</topic><topic>Time Factors</topic><topic>Whipple's operation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wakeman, Christopher J.</creatorcontrib><creatorcontrib>Martin, Ian G.</creatorcontrib><creatorcontrib>Robertson, Robert W.</creatorcontrib><creatorcontrib>Dobbs, Bruce R.</creatorcontrib><creatorcontrib>Frizelle, Frank A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>ANZ journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wakeman, Christopher J.</au><au>Martin, Ian G.</au><au>Robertson, Robert W.</au><au>Dobbs, Bruce R.</au><au>Frizelle, Frank A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pancreatic cancer: management and survival</atitle><jtitle>ANZ journal of surgery</jtitle><addtitle>ANZ J Surg</addtitle><date>2004-11</date><risdate>2004</risdate><volume>74</volume><issue>11</issue><spage>941</spage><epage>944</epage><pages>941-944</pages><issn>1445-1433</issn><eissn>1445-2197</eissn><abstract>Aim: To review the management and survival from all pancreatic cancer over a 5‐year period at a tertiary referral hospital in New Zealand and to examine similar outcome data from the national cancer registry.
Methods: A retrospective audit was conducted for the 5‐year period 1994−99 of patients discharged from Christchurch Hospital (Christchurch, New Zealand) and all patients in the New Zealand Cancer Registry with a diagnosis of pancreatic cancer. Kaplan− Meier survival curves were used for analysis.
Results: From Christchurch Hospital a total of 230 patients were identified with a discharge diagnosis of pancreatic cancer. Medium survival for all groups was 3.9 months. There was a median survival of 1.6 months for the non‐interventional group, 3.1 months for the stent group, 6.2 months for the bypass group and 12.6 months for the pancreatico‐duodenectomy group. These data are very similar to the New Zealand National Cancer Registry data, where the overall median survival was 3.1 months and median survival for a pancreatico‐duodenectomy was 13.9 months.
Conclusion: A pancreatico‐duodenectomy is usually a palliative surgical technique and not a curative procedure. Those selected for resection have been shown to have an advantage over operative bypass in terms of length of survival, however, this most likely reflects selection bias.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Pty</pub><pmid>15550079</pmid><doi>10.1111/j.1445-1433.2004.03210.x</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1445-1433 |
| ispartof | ANZ journal of surgery, 2004-11, Vol.74 (11), p.941-944 |
| issn | 1445-1433 1445-2197 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67085869 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Adenocarcinoma - mortality Adenocarcinoma - surgery Adenocarcinoma - therapy Aged bypass Cancer Case-Control Studies Cholangiopancreatography, Endoscopic Retrograde Disease management Female Humans Male New Zealand - epidemiology palliative Palliative Care Pancreas Pancreatic cancer Pancreatic Neoplasms - mortality Pancreatic Neoplasms - surgery Pancreatic Neoplasms - therapy pancreatico-duodenectomy Pancreaticoduodenectomy Registries - statistics & numerical data Retrospective Studies stent Stents Surgery survival Survival Analysis Survival Rate Time Factors Whipple's operation |
| title | Pancreatic cancer: management and survival |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T06%3A48%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pancreatic%20cancer:%20management%20and%20survival&rft.jtitle=ANZ%20journal%20of%20surgery&rft.au=Wakeman,%20Christopher%20J.&rft.date=2004-11&rft.volume=74&rft.issue=11&rft.spage=941&rft.epage=944&rft.pages=941-944&rft.issn=1445-1433&rft.eissn=1445-2197&rft_id=info:doi/10.1111/j.1445-1433.2004.03210.x&rft_dat=%3Cproquest_cross%3E824920731%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198225975&rft_id=info:pmid/15550079&rfr_iscdi=true |